C21 Investments Inc. (CXXI.CN)
C21 Investments Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.38, down 2.56% on the session, giving a market capitalisation of $45.1M. Its beta of 1.88 implies it has historically moved more than the broad market.
C21 Investments Inc. operates as a comprehensive enterprise within the cannabis sector, handling the cultivation, processing, distribution, and retail of consumer goods derived from cannabis and hemp throughout the United States. Its diverse product lineup includes both pre-packaged and bulk cannabis flower, vaporizer cartridges, concentrated extracts, edible products, pre-rolled joints, liquid tinctures, and topical applications. In addition, the company provides payroll administration and employee benefits solutions. Originally incorporated in 1987, the firm rebranded to C21 Investments Inc. in November 2017, having previously operated under the name Curlew Lake Resources Inc. Its primary corporate headquarters are situated in Vancouver, Canada.
C21 Investments Inc. is most often compared with the following Healthcare names: